Catalyst Wire Dossier Catalyst Wire Dossier

LUM-201

· Lumos Pharma
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for LUM-201, covering 2023-10-04 to 2026-06-17. Get the full timeline:

Most recent: Clinical Trial Results: Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial) [Phase 2]

See pricing